Dr Joe Live provides a wealth of wisdom to deepen your understanding of the work. Each monthly, hour-long conversation with Dr Joe includes unique insights into his tools, teachings, and meditations, plus answers to questions from our community.
Panelists discuss how challenges in implementing emerging Bruton tyrosine kinase inhibitor (BTKi) regimens for treatment-naive patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma…
Solid said that the first patients to receive its Duchenne gene therapy all produced high levels of the target protein, an early sign of promise
Health care providers say that hesitation and outright resistance to vaccines have become disturbingly common even in Massachusetts, a state that was at the forefront…
Stress is hard on your heart. But all you need is a few minutes a day to relax into healthier blood pressure and lower cardiac…
Recent advancements in the formulation of solid dosage forms involving active ingredient-cyclodextrin complexes have garnered considerable attention in pharmaceutical research. While previous studies predominantly focused…
Solid said that the first patients to receive its Duchenne gene therapy all produced high levels of the target protein, an early sign of promise
ON THE EVENING of November 19, art adviser Adam Biesk was finishing work at his California home when he overheard a conversation between his wife…
Biogen and Stoke Therapeutics have signed a deal to co-develop and sell Stoke’s experimental drug for Dravet syndrome, outside the U.S.
Europe’s leaders are caught between the need to boost their defence spending in a hurry, and their tight finances. The European leaders gathered by French…
